Skip to content

Impact of Iron Supplementation During Pregnancy

Impact of Iron Supplementation on Haemoglobin Levels and Quality-of-life in Iron-deficient (Anaemic) Women Before and After Delivery

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07814378
Enrollment
800
Registered
2026-09-11
Start date
2026-10-01
Completion date
2028-12-31
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Iron Deficiency Anaemia in Childbirth, Pregnancy

Keywords

Pregancy, Iron deficiency, Anemia

Brief summary

During pregnancy, iron deficiency is the most common cause of anemia. Anemia is very common during pregnancy and after childbirth. Around half of pregnant women develop anemia, and after delivery, up to 85% of women may be affected. This study looks at whether iron given through a vein (intravenous iron) can improve blood levels and how women feel and function in everyday life before and after giving birth.

Interventions

DRUGIron

Iron supplementation will be performed according to Hamza et al., Recommendations of the AGG (Obstetrics Working Group, Section for Maternal Diseases) for the Management of Anemia in Pregnancy - Part 1 (Iron Deficiency Anemia) (https://www.thieme-connect.com/products/ejournals/pdf/10.1055/a-2628-7308.pdf)

Sponsors

Johann Wolfgang Goethe University Hospital
Lead SponsorOTHER
Wuerzburg University Hospital
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pregnancy

Exclusion criteria

* Thalassemia * Sickle cell disease * Aplastic anemia * Hemochromatosis * Chronic inflammatory diseases associated with anemia of chronic disease * Severe renal insufficiency * Intravenous iron administration within 3 months prior to enrollment

Design outcomes

Primary

MeasureTime frameDescription
Proportion of patients achieving an increase in hemoglobin concentration of ≥1 g/dLbetween iron supplementation and follow-up: 2-4 weeksProportion of patients with an increase in hemoglobin concentration of ≥1 g/dL from before the first intravenous iron administration to the last available measurement before delivery

Countries

Germany

Contacts

CONTACTSuma Choorapoikayil, PhD
Choorapoikayil@med.uni-frankfurt.de049-069-6301-83169
CONTACTPatrick Meybohm, MD
meybohm_p@ukw.de+49 931 201-30001

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026